4.7 Article

Nanoparticles Produced by Ring-Opening Metathesis Polymerization Using Norbornenyl-poly(ethylene oxide) as a Ligand-Free Generic Platform for Highly Selective In Vivo Tumor Targeting

Journal

BIOMACROMOLECULES
Volume 14, Issue 7, Pages 2396-2402

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/bm400516b

Keywords

-

Funding

  1. Agence Nationale de la Recherche (ANR) [ANR-08-PCVI-030]
  2. Centre National de la Recherche Scientifique (CNRS)
  3. Ligue Contre le Cancer
  4. committees of Morbihan
  5. Sarthe
  6. Vendee et Loire-Atlantique
  7. Poitou-Chanrentes
  8. ARSMESO44
  9. Nantes University Hospital
  10. COST Action [TD0905]
  11. Ligue Nationale Contre le Cancer

Ask authors/readers for more resources

We described a norbornenyl-poly(ethylene oxide) nanoparticles ligand-free generic platform, made fluorescent with straightforward preparation by ring-opening metathesis polymerization (ROMP). Our method allowed to easily obtain a drug delivery system (DDS) with facilitated functionalization by means of azide-alkyne click chemistry and with a high selectivity for the tumor in vivo, while cellular internalization is obtained without cell targeting strategy. We demonstrated that our nanoparticles are internalized by endocytosis and colocalized with acidic intracellular compartments in two models of aggressive tumoral cell lines with low prognostic and limited therapeutic treatments. Our nanoparticles could be of real interest to limit the toxicity and to increase the clinical benefit of drugs suffering rapid clearance and side effects and an alternative for cancers with poorly efficient therapeutic solutions by associating the drug delivery in the tumor tissue with an acid-sensitive release system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development

Suna Sun, Francesca Frontini, Weihong Qi, Ananya Hariharan, Manuel Ronner, Martin Wipplinger, Christophe Blanquart, Hubert Rehrauer, Jean-Francois Fonteneau, Emanuela Felley-Bosco

Summary: Early events in mesothelioma development involve increased levels of editing in double-stranded RNA (dsRNA). Expression of endogenous retroviruses (ERV) contributes to dsRNA formation and type-I interferon signaling. These findings may have implications for early diagnosis and treatment strategies.

CANCER LETTERS (2021)

Article Multidisciplinary Sciences

A partially demineralized allogeneic bone graft: in vitro osteogenic potential and preclinical evaluation in two different intramembranous bone healing models

Pierre Tournier, Jerome Guicheux, Arnaud Pare, Aymeric Maltezeanu, Thibaut Blondy, Joelle Veziers, Caroline Vignes, Manon Andre, Julie Lesoeur, Ana Barbeito, Raphael Bardonnet, Christophe Blanquart, Pierre Corre, Valerie Geoffroy, Pierre Weiss, Alexis Gaudin

Summary: Partially demineralized allogenic bone paste is a novel bone graft with superior bone regeneration and osteogenic potential, making it a promising alternative to allogeneic bone grafts for bone regeneration in oral and maxillofacial clinical contexts.

SCIENTIFIC REPORTS (2021)

Article Medicine, Research & Experimental

KRAS signaling in malignant pleural mesothelioma

Antonia Marazioti, Anthi C. Krontira, Sabine J. Behrend, Georgia A. Giotopoulou, Giannoula Ntaliarda, Christophe Blanquart, Hasan Bayram, Marianthi Iliopoulou, Malamati Vreka, Lilith Trassl, Mario A. A. Pepe, Caroline M. Hackl, Laura Klotz, Stefanie A. Weiss, Ina Koch, Michael Lindner, Rudolph A. Hatz, Juergen Behr, Darcy E. Wagner, Helen Papadaki, Sophia G. Antimisiaris, Didier Jean, Sophie Deshayes, Marc Gregoire, Ozgecan Kayalar, Deniz Mortazavi, Sukru Dilege, Serhan Tanju, Suat Erus, Omer Yavuz, Pinar Bulutay, Pinar Firat, Ioannis Psallidas, Magda Spella, Ioanna Giopanou, Ioannis Lilis, Anne-Sophie Lamort, Georgios T. Stathopoulos

Summary: A portion of human MPM cases have mutations in KRAS, and mouse models suggest that KRAS mutations can lead to MPM, especially when combined with TP53 deletion. These findings indicate that KRAS alterations may play an important and underestimated role in certain MPM patients.

EMBO MOLECULAR MEDICINE (2022)

Article Cell & Tissue Engineering

Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways

Marine Charrier, Judith Lorant, Rafael Contreras-Lopez, Gautier Tejedor, Christophe Blanquart, Blandine Lieubeau, Cindy Schleder, Isabelle Leroux, Sophie Deshayes, Jean-Francois Fonteneau, Candice Babarit, Antoine Hamel, Armelle Magot, Yann Pereon, Sabrina Viau, Bruno Delorme, Patricia Luz-Crawford, Guillaume Lamirault, Farida Djouad, Karl Rouger

Summary: The study demonstrates that hMuStem cells possess an immunosuppressive phenotype and can inhibit T-cell proliferation and cytotoxic response while promoting the generation of regulatory T cells through both direct contact and secretion of soluble factors. The secretion profile of hMuStem cells is shown to be superior to that of BM-MSCs. These findings reinforce the candidacy of hMuStem cells as therapeutic agents for MDs.

STEM CELL RESEARCH & THERAPY (2022)

Article Engineering, Biomedical

Influence of the mechanical and geometrical parameters on the cellular uptake of nanoparticles: A stochastic approach

Sarah Iaquinta, Shahram Khazaie, Elena Ishow, Christophe Blanquart, Sylvain Freour, Frederic Jacquemin

Summary: In this paper, the influence of nanoparticles' mechanical and geometrical properties on their cellular uptake was numerically investigated. The results revealed that the aspect ratio of the particle had the greatest impact on the wrapping of the particle by the cell membrane, with adhesion contributing twice as much as membrane tension.

INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING (2022)

Review Pharmacology & Pharmacy

Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies

Daniel L. Pouliquen, Alice Boissard, Cecile Henry, Olivier Coqueret, Catherine Guette

Summary: Curcuminoids have the potential to fight against invasive cancers by targeting multiple molecular targets, modulating signaling pathways, and enhancing the host's immune response. This review explores the role of curcuminoids in inhibiting the epithelial-to-mesenchymal transition (EMT) in cancer.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Proteomes of Residual Tumors in Curcumin-Treated Rats Reveal Changes in Microenvironment/Malignant Cell Crosstalk in a Highly Invasive Model of Mesothelioma

Daniel L. Pouliquen, Marine Malloci, Alice Boissard, Cecile Henry, Catherine Guette

Summary: Curcumin's effects on tumor microenvironment and cancer cell invasiveness were investigated in a rat model of peritoneal mesothelioma. The study found that curcumin can modulate protein abundance and affect proteins related to tumor microenvironment regulation and activated T cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition

Sabine Paternot, Eric Raspe, Clement Meiller, Maxime Tarabichi, Jean-Baptiste Assie, Frederick Libert, Myriam Remmelink, Xavier Bisteau, Patrick Pauwels, Yuna Blum, Nolwenn Le Stang, Severine Tabone-Eglinger, Francoise Galateau-Salle, Christophe Blanquart, Jan P. Van Meerbeeck, Thierry Berghmans, Didier Jean, Pierre P. Roger

Summary: This study evaluated the impact of CDK4/6 inhibition by palbociclib in malignant pleural mesothelioma (MPM) and found that MPM is uniquely sensitive to CDK4/6 inhibitors. Palbociclib can durably inhibit cell proliferation, even after drug washout, and induce a senescence-associated secretory phenotype. The study supports the evaluation of CDK4/6 inhibitors as monotherapy or combination therapy for MPM treatment.

MOLECULAR ONCOLOGY (2022)

Article Oncology

Long-Chain Acyl Coenzyme A Dehydrogenase, a Key Player in Metabolic Rewiring/Invasiveness in Experimental Tumors and Human Mesothelioma Cell Lines

Daniel L. Pouliquen, Giacomo Ortone, Letizia Rumiano, Alice Boissard, Cecile Henry, Stephanie Blandin, Catherine Guette, Chiara Riganti, Joanna Kopecka

Summary: Cross-species investigations of cancer invasiveness have identified new biomarkers for improving tumor diagnosis and prognosis. This study analyzed rat tumors and human cell lines to identify common features associated with mitochondrial proteome rewiring. The differential expression of mitochondrial proteins, particularly ACADL, was found to be associated with invasiveness in mesothelioma.

CANCERS (2023)

Review Pharmacology & Pharmacy

Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future

Daniel L. Pouliquen, Koraljka Gall Troselj, Ruby John Anto

Summary: The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in carcinogenesis and tumor progression have been provided. This review will also cover the use of curcuminoids as chemosensitizing molecules that can be combined with several anticancer drugs to reverse the phenomenon of multidrug resistance.

PHARMACEUTICS (2023)

Article Oncology

Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma

Paul Stockhammer, Hannah Baumeister, Till Ploenes, Francesco Bonella, Dirk Theegarten, Balazs Dome, Christine Pirker, Walter Berger, Luca Hegedues, Marcell Baranyi, Martin Schuler, Sophie Deshayes, Servet Bolukbas, Clemens Aigner, Christophe Blanquart, Balazs Hegedues

Summary: This study is the first to demonstrate KL-6 as a potential novel liquid-based diagnostic and prognostic biomarker in pleural mesothelioma, which may help improve patients' survival rates.

LUNG CANCER (2023)

Editorial Material Pharmacology & Pharmacy

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers

Daniel L. Pouliquen, Koraljka Gall Troselj, Ruby John Anto, Rakesh Naidu

FRONTIERS IN PHARMACOLOGY (2023)

Editorial Material Oncology

Biomarkers of Tumor Metastasis and Invasiveness

Daniel L. Pouliquen, Cristina Nunez Gonzalez

CANCERS (2023)

Review Oncology

HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature

Laurent Mathiot, Guillaume Herbreteau, Simeon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Denis, Elvire Pons-Tostivint

Summary: The occurrence of HRAS mutations in NSCLC patients is low, and there is limited research data on the clinical characteristics and treatment response of these patients. This study identified four NSCLC patients with HRAS p.Gln61Leu mutation using Next-Generation Sequencing and reviewed relevant literature. The results showed that most cases had pleural or pericardial effusion at diagnosis, and some patients died during first-line therapy. Further research is needed to clarify the prognosis and treatment response of HRAS-mutant NSCLC patients.

CURRENT ONCOLOGY (2022)

Article Chemistry, Multidisciplinary

Impact of RAFT chain transfer agents on the polymeric shell density of magneto-fluorescent nanoparticles and their cellular uptake

Thibaut Blondy, Julien Poly, Camille Linot, Joanna Boucard, Emilie Allard-Vannier, Steven Nedellec, Phillipe Hulin, Celine Henoumont, Lionel Larbanoix, Robert N. Muller, Sophie Laurent, Elena Ishow, Christophe Blanquart

Summary: The surface chemistry of nanoparticles has a significant impact on their cellular uptake, and the residual groups of chain transfer agents (CTAs) introduced in the main chain can modulate the cell uptake of nanoparticles. This study demonstrates that the cellular internalization of functionalized nanoparticles can be controlled by the compaction of the PEG comb-like shell incorporating CTAs with a long alkyl chain, without changing the overall surface potential.

NANOSCALE (2022)

No Data Available